Yuyu Pharm wins EU patent for its ticlopidine plus ginkgo biloba extract patent

Published: 2004-05-11 06:56:00

Updated: 2004-05-11 06:56:00

Yuyu Pharm says it has recently won from European Union a patent relating to a novel pharmaceutical composition containing ticlopidine and ginkgo biloba extract after acquisition of Korea and US patents.

Ticlopidine, a platelet inhibitor, has been used in the treatment of a variety of disease ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK